Skip to main content

Newsroom press releases

05/09/24 - 11:17

DiaSorin S.p.A. - Update 2024 Annual Calendar of Corporate Events (99.93 KB)
Other

04/09/24 - 11:36

Diasorin S.p.A. - Shareholders' Meeting September 4, 2024 (136.09 KB)
Other

24/04/24 - 15:38

Shareholders' Meeting 2024 (159.72 KB)
Other

16/04/24 - 8:20

Communication on total amount of voting rights (135.47 KB)
Other

24/10/23 - 15:03

Diasorin unveils its new Corporate identity and launches the new Group website: www.diasorin.com (574.08 KB)
Other

27/07/23 - 14:27

Update 2023 Annual Calendar of Corporate Events (104.1 KB)
Other

03/07/23 - 11:48

Suspension of the effectiveness of the disqualifying accessory administrative sanction imposed by CONSOB to the Chief Executive Officer Mr. Carlo Rosa (102.52 KB)
Other

05/06/23 - 21:58

Administrative sanctions imposed by CONSOB in connection with the alleged breach to disclose obligations relating to inside information. Action for annulment. (107.91 KB)
Other

26/05/23 - 7:10

DIASORIN CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM (159.38 KB)
Acquisition / Partnership

28/04/23 - 12:52

Shareholders' Meeting 2023 (373.48 KB)
Other

28/02/23 - 16:06

Sale of Flow Cytometry and Imaging business from DiaSorin to Cytek® Biosciences completed (130.89 KB)
Acquisition / Partnership

13/02/23 - 22:03

CYTEK BIOSCIENCES TO ACQUIRE FLOW CYTOMETRY AND IMAGING BUSINESS FROM DIASORIN (165.22 KB)
Acquisition / Partnership

01/12/22 - 18:30

2023 Annual Calendar of Corporate Events (288 KB)
Other

07/06/22 - 18:06

Execution of the project for the redefinition of the corporate structure of DiaSorin (286.22 KB)
Other

09/05/22 - 7:02

DiaSorin and B·R·A·H·M·S, part of Thermo Fisher Scientific, partner to develop and commercialize the new LIAISON® B·R·A·H·M·S MR-proADM™ (173.49 KB)
Acquisition / Partnership

29/04/22 - 16:26

Shareholders' meeting 2022 (166.12 KB)
Other

05/04/22 - 9:51

Notice pursuant to art. 144-octies, paga 2 of Consob Regulation No. 11971/1999 (309.07 KB)
Other

04/04/22 - 18:12

Filing of the lists submitted by IP Investimenti e Partecipazioni S.r.l. (577.98 KB)
Other

21/12/21 - 11:07

2022 Annual Calendar of Corporate Events (296.13 KB)
Other

05/11/21 - 11:22

Weekly report treasury shares buy-back (2.15 MB)
Other

02/11/21 - 20:00

Conclusion treasury shares buy-back plan (294.67 KB)
Other

02/11/21 - 19:57

Weekly report treasury shares buy-back (3.5 MB)
Other

27/10/21 - 16:35

Issuance of the "Physical Settlement Notice" (517.5 KB)
Other

07/10/21 - 11:45

Publication of the summary report of the votes (290.08 KB)
Other

04/10/21 - 12:27

The Extraordinary Shareholders' Meeting of DiaSorin authorizes the convertibility of the equity-linked bond and the share capital increase (297.73 KB)
Other

30/07/21 - 18:43

Start up of the treasury shares buy-back plan (773.96 KB)
Other

22/07/21 - 18:28

Publication of Information Document under the provisions of the art. 71 of the CONSOB Regulation n. 11971/1999 (303.95 KB)
Other

14/07/21 - 15:05

DiaSorin announces completion of the Acquisition of Luminex Corporation (566.52 KB)
Acquisition / Partnership

09/07/21 - 7:34

DiaSorin obtains all approvals necessary to complete the acquisition of Luminex (560.68 KB)
Acquisition / Partnership

21/06/21 - 18:49

The Shareholders’ meeting of Luminex Corporation approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin (395.62 KB)
Acquisition / Partnership

07/06/21 - 15:16

Communication on total amount of voting rights (563.42 KB)
Other

03/06/21 - 7:47

DiaSorin signs agreements with Unifarma and Alliance Healthcare for the distribution in Italian pharmacies of the LIAISON® IQ (523.42 KB)
Acquisition / Partnership

22/04/21 - 15:58

Shareholders' meeting April 22, 2021 (422.91 KB)
Other

14/04/21 - 10:05

Communication voting rights amount (544.6 KB)
Other

12/04/21 - 11:08

Weekly report treasury shares buy-back (914.42 KB)
Other

11/04/21 - 19:47

DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion (569.09 KB)
Acquisition / Partnership

06/04/21 - 8:53

Start up buy-back plan (774.02 KB)
Other

06/04/21 - 7:06

DiaSorin announces its strategic collaboration with Lumos Diagnostics (438.14 KB)
Acquisition / Partnership

27/01/21 - 18:50

2021 Annual Calendar of Corporate Events (209.87 KB)
Other

17/12/20 - 17:57

DiaSorin - Policlinico San Matteo Hospital in Pavia vs. Technogenetics (298.96 KB)
Other

07/12/20 - 10:35

Communication on total amount of voting rights (563.18 KB)
Other

04/12/20 - 16:14

Form 3F (November 2020) (10.2 KB)
Other

23/10/20 - 19:41

Conclusion treasury shares buy-back plan (314.28 KB)
Other

23/10/20 - 19:37

Weekly report treasury shares buy-back (436.92 KB)
Other

16/10/20 - 18:28

Weekly report treasury shares buy-back (425.19 KB)
Other

23/09/20 - 7:16

DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China (495.78 KB)
Acquisition / Partnership

16/09/20 - 14:30

Update Annual Calendar of Corporate Events 2020 (222.26 KB)
Other

08/09/20 - 7:31

DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution (506.16 KB)
Acquisition / Partnership

31/07/20 - 16:04

Weekly report treasury shares buy-back (380.16 KB)
Other

24/07/20 - 17:19

Weekly report treasury shares buy-back (363.73 KB)
Other

17/07/20 - 18:19

Weekly report treasury shares buy-back (360.09 KB)
Other

10/07/20 - 18:23

Weekly report treasury shares buy-back (374 KB)
Other

19/06/20 - 17:20

Weekly report treasury shares buy-back (399.38 KB)
Other

17/06/20 - 16:09

Start up of the treasury shares buy-back plan (481.28 KB)
Other

10/06/20 - 15:40

Shareholders' Meeting June 10, 2020 (308.25 KB)
Other

26/03/20 - 18:14

Update Annual Calendar of Corporate Events 2020 (277.25 KB)
Other

21/03/20 - 20:29

Shareholders' Meeting date change (288.23 KB)
Other

02/03/20 - 8:04

DiaSorin signs an exclusive licensing agreement for molecular diagnostic POC technology (396.06 KB)
Acquisition / Partnership

07/02/20 - 8:06

Communication on total amount of voting rights (281.13 KB)
Other

15/01/20 - 16:51

Annual Calendar of Corporate Events 2020 (124.73 KB)
Other

06/12/19 - 18:12

Press Release (262.61 KB)
Other

06/12/19 - 18:11

Press Release (262.7 KB)
Other

06/12/19 - 18:08

Communication on total amount of voting rights (281.87 KB)
Other

07/10/19 - 10:20

Communication on total amount of voting rights (282.21 KB)
Other

05/06/19 - 7:38

DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease (448.98 KB)
Acquisition / Partnership Immunodiagnostic

30/04/19 - 12:28

Update Annual Calendar of Corporate Events 2019 (249.43 KB)
Other

24/04/19 - 17:24

DiaSorin: Shareholders' Meeting 2019 (449.66 KB)
Other

12/04/19 - 8:59

Communication on total amount of voting rights (320.44 KB)
Other

05/04/19 - 9:33

Communication on total amount of voting rights (342.47 KB)
Other

03/04/19 - 20:18

Lists publication (79.68 KB)
Other

07/03/19 - 11:45

Communication on total amount of voting rights (350.08 KB)
Other

06/03/19 - 8:45

A new Group website for DiaSorin: www.diasoringroup.com (154.5 KB)
Other

07/02/19 - 15:15

Communication on total amount of voting rights (February 7, 2019) (349.86 KB)
Other

09/10/18 - 11:35

DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership

08/01/18 - 9:00

QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership

29/11/17 - 19:30

Resignation of a Strategic Executive of the Company (233.58 KB)
Other

29/09/17 - 14:15

DiaSorin completes the acquisition of the ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (332.93 KB)
Acquisition / Partnership

25/07/17 - 21:00

DiaSorin to acquire ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (443.45 KB)
Acquisition / Partnership

23/06/17 - 9:30

DiaSorin and TECAN to collaborate in new platform development (755.46 KB)
Acquisition / Partnership

22/06/17 - 19:45

DiaSorin and QIAGEN sign collaboration to expand Liaison test menu through adoption of select QIAGEN assays (430.67 KB)
Acquisition / Partnership

30/08/16 - 2:00

DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)
Acquisition / Partnership

13/05/16 - 2:00

Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)
Acquisition / Partnership

30/03/16 - 2:00

DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)
Acquisition / Partnership

20/07/15 - 2:00

DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)
Acquisition / Partnership

12/05/15 - 2:00

DiaSorin presents the 2015-2017 industrial plan (305.81 KB)
Other

28/01/14 - 1:00

DiaSorin extends its master agreement with Laboratory Corporation of America Holdings till 2018 (336.26 KB)
Acquisition / Partnership

29/10/13 - 1:00

DiaSorin signes a 5-year agreement with Roche (432.42 KB)
Acquisition / Partnership

02/04/13 - 2:00

DiaSorin signs an agreement with Seegene (243.64 KB)
Acquisition / Partnership

30/07/12 - 2:00

DiaSorin in India: JV with Trivitron Healthcare (56.16 KB)
Acquisition / Partnership

04/05/12 - 2:00

NorDiag acquisition (88.87 KB)
Acquisition / Partnership

12/03/12 - 1:00

Agreement with Sonic Healthcare on Vitamin D (179.85 KB)
Acquisition / Partnership

17/02/12 - 1:00

DiaSorin became a member of the ISBT (178.96 KB)
Acquisition / Partnership

19/01/12 - 1:00

Prize for best Italian Company in R&D in the UK (183.95 KB)
Other

10/10/11 - 2:00

New Chief Financial Officer (196.26 KB)
Other

06/10/11 - 2:00

Cardinal Health: agreement extended to 2014 (192.57 KB)
Acquisition / Partnership

01/09/11 - 2:00

Resignation of Chief Financial Officer (177.77 KB)
Other

11/05/11 - 2:00

DiaSorin and Labcorp extend strategic business relationship (100.01 KB)
Acquisition / Partnership

06/05/11 - 2:00

Agreement with Precision System Science Co., LTD (171.54 KB)
Acquisition / Partnership

17/01/11 - 1:00

The Sonic Healthcare Group chooses DiaSorin (181.71 KB)
Acquisition / Partnership

07/07/10 - 2:00

Agreement with Meridian Inc. (182.7 KB)
Acquisition / Partnership

01/06/10 - 2:00

Acquisition of MUREX product line (102.6 KB)
Acquisition / Partnership

10/03/10 - 1:00

Acquisition of MUREX product line (45.5 KB)
Acquisition / Partnership

12/10/09 - 2:00

Strengthening of group's R&D team (99.72 KB)
Other

22/09/08 - 2:00

Agreement in Japan with Advanced Life Science Institute (99.16 KB)
Acquisition / Partnership

09/07/08 - 2:00

Acquisition of Biotrin (99.08 KB)
Acquisition / Partnership